A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-Up.

empty sella hypogonadism hypopituitarism intracranial hypertension neuroendocrinology pituitary sella turcica traumatic brain injury

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 21 04 2022
accepted: 19 05 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

primary empty sella (PES) represents a frequent finding, but data on hormonal alterations are heterogeneous, and its natural history is still unclear. Our aim was to evaluate the pituitary function of patients with PES over a long follow-up. multicenter retrospective cohort study enrolling patients referred between 1984-2020 to five Pituitary Units, with neuroradiological confirmed PES and a complete hormonal assessment. we analyzed hormonal (including basal and dynamic evaluations), clinical and neuroradiological data collected at diagnosis and at the last visit (at least 6 months of follow-up). we recruited 402 patients (females=63%, mean age=51.5 ± 16 years) with PES (partial, total, undefined in 66%, 13% and 21%, respectively). Hypopituitarism was present in 40.5% (hypogonadism=20.4%, hypoadrenalism=14.7%, growth hormone deficiency=14.7%, hypothyroidism=10.2%, diabetes insipidus=1.5%; multiple deficiencies=11.4%) and hypeprolactinemia in 6.5%. Interestingly, hormonal alterations were diagnosed in 29% of incidental PES. Hypopituitarism was associated with male sex ( this is the largest cohort of patients with PES reported. Hypopituitarism is frequent (40%) but hormonal deterioration seems uncommon (3%). Patients need to be carefully evaluated at diagnosis, even if PES is incidentally discovered.

Identifiants

pubmed: 35813618
doi: 10.3389/fendo.2022.925378
pmc: PMC9259926
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

925378

Informations de copyright

Copyright © 2022 Carosi, Brunetti, Mangone, Baldelli, Tresoldi, Del Sindaco, Lavezzi, Sala, Mungari, Fatti, Galazzi, Ferrante, Indirli, Biamonte, Arosio, Cozzi, Lania, Mazziotti and Mantovani.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Endocrinol Invest. 2002 Mar;25(3):236-9
pubmed: 11936465
Minerva Endocrinol. 1989 Jan-Mar;14(1):1-18
pubmed: 2659952
Endocrinol Metab Clin North Am. 1995 Sep;24(3):549-72
pubmed: 8575409
J Clin Endocrinol Metab. 2005 Sep;90(9):5471-7
pubmed: 15972577
J Clin Endocrinol Metab. 1972 Mar;34(3):570-3
pubmed: 4334769
Turk Neurosurg. 2014;24(3):374-9
pubmed: 24848177
Dtsch Arztebl Int. 2018 Feb 16;115(7):99-105
pubmed: 29510819
Pituitary. 2013 Jun;16(2):270-4
pubmed: 22875743
Eur J Endocrinol. 2005 Aug;153(2):257-64
pubmed: 16061832
J Endocrinol Invest. 2011 Sep;34(8):e240-4
pubmed: 21623153
J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59
pubmed: 20525905
J Clin Endocrinol Metab. 2013 May;98(5):1781-8
pubmed: 23650335
Australas Radiol. 2000 Aug;44(3):341-8
pubmed: 10974735
Curr Opin Endocrinol Diabetes Obes. 2019 Jun;26(3):139-145
pubmed: 30855285
J Clin Endocrinol Metab. 2008 Nov;93(11):4245-53
pubmed: 18697868
J Neurosurg. 1968 Feb;28(2):93-9
pubmed: 5638016
Radiol Med. 1991 Jun;81(6):803-7
pubmed: 1857785
Ann Endocrinol (Paris). 2016 Oct;77(5):620-622
pubmed: 27449530
Am J Med. 1977 Apr;62(4):569-80
pubmed: 851132
J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609
pubmed: 21602453
Endocr Rev. 2015 Jun;36(3):305-42
pubmed: 25950715
Lancet Neurol. 2017 Jan;16(1):76-87
pubmed: 27836433
J Endocrinol Invest. 2010 May;33(5):343-6
pubmed: 20208457
J Clin Endocrinol Metab. 2016 Feb;101(2):427-34
pubmed: 26649617
Clin Endocrinol (Oxf). 2013 Aug;79(2):211-6
pubmed: 23215853
J Clin Endocrinol Metab. 2016 Nov;101(11):3888-3921
pubmed: 27736313
Eur J Endocrinol. 2017 Dec;177(6):R275-R285
pubmed: 28780516

Auteurs

Giulia Carosi (G)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.
Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy.

Alessandro Brunetti (A)

Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy.
IRCCS Humanitas Research Hospital, Endocrinology, Diabetology and Andrology Unit, Rozzano, Italy.

Alessandra Mangone (A)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.
University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.

Roberto Baldelli (R)

A.O. San Camillo Forlanini, Endocrinology Unit, Department of Oncology and Medical Specialities, Rome, Italy.

Alberto Tresoldi (A)

Humanitas Gavazzeni, Endocrinologia, Bergamo, Italy.

Giulia Del Sindaco (G)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.
University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.

Elisabetta Lavezzi (E)

IRCCS Humanitas Research Hospital, Endocrinology, Diabetology and Andrology Unit, Rozzano, Italy.

Elisa Sala (E)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.

Roberta Mungari (R)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.

Letizia Maria Fatti (LM)

IRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.

Elena Galazzi (E)

IRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.

Emanuele Ferrante (E)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.

Rita Indirli (R)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.
University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.

Emilia Biamonte (E)

IRCCS Humanitas Research Hospital, Endocrinology, Diabetology and Andrology Unit, Rozzano, Italy.

Maura Arosio (M)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.
University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.

Renato Cozzi (R)

Niguarda Hospital, Division of Endocrinology, Milan, Italy.

Andrea Lania (A)

Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy.
IRCCS Humanitas Research Hospital, Endocrinology, Diabetology and Andrology Unit, Rozzano, Italy.

Gherardo Mazziotti (G)

Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy.
IRCCS Humanitas Research Hospital, Endocrinology, Diabetology and Andrology Unit, Rozzano, Italy.

Giovanna Mantovani (G)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy.
University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH